Literature DB >> 2039995

Analysis of point mutations in an ultraviolet-irradiated shuttle vector plasmid propagated in cells from Japanese xeroderma pigmentosum patients in complementation groups A and F.

T Yagi1, J Tatsumi-Miyajima, M Sato, K H Kraemer, H Takebe.   

Abstract

To assess the contribution to mutagenesis by human DNA repair defects, a UV-treated shuttle vector plasmid, pZ189, was passed through fibroblasts derived from Japanese xeroderma pigmentosum (XP) patients in two different DNA repair complementation groups (A and F). Patients with XP have clinical and cellular UV hypersensitivity, increased frequency of skin cancer, and defects in DNA repair. The XP DNA repair defects represented by complementation groups A (XP-A) and F (XP-F) are more common in Japan than in Europe or the United States. In comparison to results with DNA repair-proficient human cells (W138-VA13), UV-treated pZ189 passed through the XP-A [XP2OS(SV)] or XP-F [XP2YO(SV)] cells showed fewer surviving plasmids (XP-A less than XP-F) and a higher frequency of mutated plasmids (XP-A greater than XP-F). Base sequence analysis of more than 200 mutated plasmids showed the major type of base substitution mutation to be the G:C----A:T transition with all three cell lines. The XP-A and XP-F cells revealed a higher frequency of G:C----A:T transitions and a lower frequency of transversions among plasmids with single or tandem mutations and a lower frequency of plasmids with multiple point mutations compared to the normal line. The spectrum of mutations in pZ189 with the XP-A cells was similar to that with the XP-F cells. Seventy-six to 91% of the single base substitution mutations occurred at G:C base pairs in which the 5'-neighboring base of the cytosine was thymine or cytosine. These studies indicate that the DNA repair defects in Japanese XP patients in complementation groups A and F result in different frequencies of plasmid survival and mutagenesis but in similar types of mutagenic abnormalities despite marked differences in clinical features. These results, together with comparable studies from United States patients in XP complementation groups A and D, suggest that G:C----A:T somatic mutations may be important in the generation of human skin cancer by UV radiation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039995

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Specific tandem GG to TT base substitutions induced by acetaldehyde are due to intra-strand crosslinks between adjacent guanine bases.

Authors:  T Matsuda; M Kawanishi; T Yagi; S Matsui; H Takebe
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

2.  An Active Learning Framework Improves Tumor Variant Interpretation.

Authors:  Alexandra M Blee; Bian Li; Turner Pecen; Jens Meiler; Zachary D Nagel; John A Capra; Walter J Chazin
Journal:  Cancer Res       Date:  2022-08-03       Impact factor: 13.312

3.  Evidence from mutation spectra that the UV hypermutability of xeroderma pigmentosum variant cells reflects abnormal, error-prone replication on a template containing photoproducts.

Authors:  Y C Wang; V M Maher; D L Mitchell; J J McCormick
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

4.  Stochastic and reversible assembly of a multiprotein DNA repair complex ensures accurate target site recognition and efficient repair.

Authors:  Martijn S Luijsterburg; Gesa von Bornstaedt; Audrey M Gourdin; Antonio Z Politi; Martijn J Moné; Daniël O Warmerdam; Joachim Goedhart; Wim Vermeulen; Roel van Driel; Thomas Höfer
Journal:  J Cell Biol       Date:  2010-05-03       Impact factor: 10.539

5.  Mutations in ras genes in cells cultured from mouse skin tumors induced by ultraviolet irradiation.

Authors:  C Nishigori; S Wang; J Miyakoshi; M Sato; T Tsukada; T Yagi; S Imamura; H Takebe
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

6.  Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue.

Authors:  Nikhil R Bhagwat; Vera Y Roginskaya; Marie B Acquafondata; Rajiv Dhir; Richard D Wood; Laura J Niedernhofer
Journal:  Cancer Res       Date:  2009-09-01       Impact factor: 12.701

7.  Measuring ERCC1 protein expression in cancer specimens: validation of a novel antibody.

Authors:  David Hersi Smith; Anne-Marie Kanstrup Fiehn; Louise Fogh; Ib Jarle Christensen; Tine Plato Hansen; Jan Stenvang; Hans Jørgen Nielsen; Kirsten Vang Nielsen; Jane Preuss Hasselby; Nils Brünner; Sussie Steen Jensen
Journal:  Sci Rep       Date:  2014-03-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.